tirzepatide and niacinamide compound / Tirzepatide and niacinamide: A comprehensive

Ofte,n people are put on a weight loss drug with no lifestyle counseling, protocol, or monitoring to preserve their muscle mass

Gout: diagnosis and management Recommendations (NG219)

degludec assoc with: Liver fat content (LFC) 18-28% Both in either HbA1c or weight assoc with Both the visceral & subcutaneous abdominal fat equally ALT 4-22% AST 10-19% SURPASS-3 MRI trial (3/3) tirzepatide (particularly 10-15mg doses) looks to be possible treatments for #NAFLD #NASH, as well as #type2diabetes ongoing liver outcome RCT with liver biopsy clinicaltrials.gov/ct2/show/NCT04SURPASS-3 CGM (1/2) another sub-study of SURPASS-3 (n=243) Dexcom G6 CGM used 1ry outcome - Time within Tight Target range 3.9-7.8 mmol/mol (71-140 mg/dL) at 24 + 52w % time within standard target range 3.9-10 mmol/mol (71-180 mg/dL) at 52w Presented by @TBattelinoSURPASS - CGM (2/2) tirzepatide treatment assoc with: Marked in Tight TIR compared to ins

These additional factors can change the cost of the procedure

This is a genuine advantage